Search

everythinglearnresearchcommunity

for

Search:↓

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

The ointment effectively treats neurodermatitis and chronic eczema without causing skin irritation.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

Topiramate may help improve disruptive behaviors in children with bipolar disorder.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Acitretin is effective for certain types of psoriasis, safe for long-term use, and often combined with other treatments.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Advanced delivery systems can make dithranol more effective and less irritating for treating psoriasis.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

Bromhexine and spironolactone together reduced COVID-19 symptoms and hospitalization time without side effects.

Recent legal rulings favored Genentech, Teva, and upheld guidelines for patent term extensions.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Avacopan may cause unexpected side effects, so early monitoring is important.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Spanlastics can improve drug delivery by effectively penetrating biological membranes.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.